A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants with Primary Biliary Cholangitis (PBC)

  • Pianko, Stephen (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date20/08/24 → 19/08/29